AL

Angelini Lumira Biosciences Fund

North America, Maryland, United States, Rockville

Description

Angelini Lumira Biosciences Fund is a corporate venture capital fund established by Angelini Pharma.

Investor Profile

Angelini Lumira Biosciences Fund has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 100% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Health Care, Biotechnology, Medical.

Stage Focus

  • Seed (50%)
  • Series B (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Neuroscience
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Angelini Lumira Biosciences Fund frequently co-invest with?

Angelini Ventures
Europe, Lazio, Italy, Rome
Co-Investments: 1
UL
North America, Virginia, United States, Charlottesville
Co-Investments: 1
3B Future Health Fund
Europe, Bayern, Germany, Monaco
Co-Investments: 1
LivaNova
Europe, England, United Kingdom, London
Co-Investments: 1
Mayo Clinic
North America, Minnesota, United States, Rochester
Co-Investments: 1
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Virginia Innovation Partnership Corporation
North America, Virginia, United States, Richmond
Co-Investments: 1
PV
North America, Georgia, United States, Loganville
Co-Investments: 1
KC
North America, Virginia, United States, Reston
Co-Investments: 1
Jazz Venture Partners
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by Angelini Lumira Biosciences Fund?

Cadence Neuroscience

Redmond, Washington, United States

Cadence Neuroscience is an early-stage company developing medical device therapies for epilepsy.

Health CareNeuroscienceTherapeutics
Series BFeb 28, 2023
Amount Raised: $26,029,994
GenEp

Charlottesville, Virginia, United States

GenEp is a pre-clinical stage biotechnology company based on intellectual property assets.

BiotechnologyHealth CareMedical
SeedOct 26, 2021
Amount Raised: $1,450,000

Find More Investors Like Angelini Lumira Biosciences Fund

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Angelini Lumira Biosciences Fund | Pipeseed